Skip to main content
SpringerLink
Log in

46-Year-Old with Psoriasis and Chronic Hepatitis C

  • Chapter
  • First Online:
Clinical Cases in Psoriasis

Part of the book series: Clinical Cases in Dermatology ((CLIDADE))

  • 497 Accesses

Abstract

Hepatitis C (HCV) is a viral infection that is associated with a higher risk of psoriasis. Treatment of psoriasis in patients with comorbid HCV is challenging because many psoriasis therapies are hepatotoxic or immunosuppressive. First-line treatments for psoriasis patients with concomitant HCV include phototherapy, topical therapies, and apremilast. Methotrexate should be avoided due to potential hepatotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. CDC. Viral hepatitis statistics and surveillance. 2016. Retrieved from United States.

    Google Scholar 

  2. Imafuku S, Naito R, Nakayama J. Possible association of hepatitis C virus infection with late-onset psoriasis: a hospital-based observational study. J Dermatol. 2013;40(10):813–8. https://doi.org/10.1111/1346-8138.12240.

    Article  CAS  PubMed  Google Scholar 

  3. Gabr SA, Berika MY, Alghadir AH. Apoptosis and clinical severity in patients with psoriasis and HCV infection. Indian J Dermatol. 2014;59(3):230–6. https://doi.org/10.4103/0019-5154.131377.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Chun K, Afshar M, Audish D, Kabigting F, Paik A, Gallo R, Hata T. Hepatitis C may enhance key amplifiers of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(4):672–8. https://doi.org/10.1111/jdv.13578.

    Article  CAS  PubMed  Google Scholar 

  5. Frankel AJ, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF Jr, et al. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;61(6):1044–55. https://doi.org/10.1016/j.jaad.2009.03.044.

    Article  PubMed  Google Scholar 

  6. Kim GW, Jwa SW, Song M, Kim HS, Kim BS, Kim MB, Ko HC. Extensive psoriasis induced by pegylated interferon alfa-2a and ribavirin in the treatment of chronic hepatitis C. Ann Dermatol. 2013;25(4):479–82. https://doi.org/10.5021/ad.2013.25.4.479.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Taylor C, Burns DA, Wiselka MJ. Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J. 2000;76(896):365–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bonifati C, Lora V, Graceffa D, Nosotti L. Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World J Gastroenterol. 2016;22(28):6444–55. https://doi.org/10.3748/wjg.v22.i28.6444.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Reddy SP, Shah VV, Wu JJ. Apremilast for a psoriasis patient with HIV and hepatitis C. J Eur Acad Dermatol Venereol. 2017;31(11):e481–2. https://doi.org/10.1111/jdv.14301.

    Article  CAS  PubMed  Google Scholar 

  10. Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol. 2012;83(12):1583–90. https://doi.org/10.1016/j.bcp.2012.01.001.

    Article  CAS  PubMed  Google Scholar 

  11. Kaushik SB, Lebwohl MG. CME Part II psoriasis: which therapy for which patient focus on special populations and chronic infections. J Am Acad Dermatol. 2018;80:43–53. https://doi.org/10.1016/j.jaad.2018.06.056.

    Article  PubMed  Google Scholar 

  12. Brunasso AM, Puntoni M, Gulia A, Massone C. Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review. Rheumatology (Oxford). 2011;50(9):1700–11. https://doi.org/10.1093/rheumatology/ker190.

    Article  CAS  Google Scholar 

  13. Zein NN. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol. 2005;42(3):315–22.

    Article  CAS  PubMed  Google Scholar 

  14. Heck JA, Meng X, Frick DN. Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase. Biochem Pharmacol. 2009;77(7):1173–80. https://doi.org/10.1016/j.bcp.2008.12.019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Navarro R, Vilarrasa E, Herranz P, Puig L, Bordas X, Carrascosa JM, et al. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting. Br J Dermatol. 2013;168(3):609–16. https://doi.org/10.1111/bjd.12045.

    Article  CAS  PubMed  Google Scholar 

  16. Chiu HY, Chen CH, Wu MS, Cheng YP, Tsai TF. The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C. Br J Dermatol. 2013;169(6):1295–303. https://doi.org/10.1111/bjd.12461.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA

    Kevin K. Wu

  2. Eastern Virginia Medical School, Norfolk, VA, USA

    Michael P. Lee

  3. Founder and CEO, Dermatology Research and Education Foundation, Irvine, CA, USA

    Jashin J. Wu

Authors
  1. Kevin K. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael P. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jashin J. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Founder and CEO, Dermatology Research and Education Foundation, Irvine, CA, USA

    Jashin J. Wu

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wu, K.K., Lee, M.P., Wu, J.J. (2019). 46-Year-Old with Psoriasis and Chronic Hepatitis C. In: Wu, J. (eds) Clinical Cases in Psoriasis. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-18772-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18772-9_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18771-2

  • Online ISBN: 978-3-030-18772-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation